(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(0.28%) $78.33
(0.19%) $2.15
(0.40%) $2 317.90
(1.72%) $27.15
(-0.54%) $960.10
(0.04%) $0.929
(-0.03%) $10.87
(0.02%) $0.797
(0.00%) $91.45
Quarter results today
(bmo 2024-05-06)
Expected move: +/- 8.91%
Live Chart Being Loaded With Signals
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases...
Stats | |
---|---|
Today's Volume | 21 950.00 |
Average Volume | 131 350 |
Market Cap | 67.25M |
EPS | $0 ( 2024-02-29 ) |
Next earnings date | ( $-0.400 ) 2024-05-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.64 |
ATR14 | $0.0300 (0.59%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-13 | Alavi Hamed | Sell | 8 334 | Stock Options |
2024-03-13 | Alavi Hamed | Buy | 8 334 | Common Stock |
2024-03-13 | Alavi Hamed | Sell | 8 334 | Common Stock |
2023-12-05 | Glynn Craig | Buy | 75 000 | Stock Options |
2023-12-05 | Jenusaitis Matthew | Buy | 13 856 | Stock Options |
INSIDER POWER |
---|
44.31 |
Last 98 transactions |
Buy: 6 344 915 | Sell: 2 475 147 |
Volume Correlation
enVVeno Medical Correlation
10 Most Positive Correlations | |
---|---|
LRMR | 0.878 |
CFLT | 0.862 |
TYRA | 0.859 |
POWL | 0.858 |
MPWR | 0.844 |
SGMO | 0.827 |
VEON | 0.825 |
LBC | 0.823 |
FWRG | 0.82 |
REYN | 0.817 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
enVVeno Medical Correlation - Currency/Commodity
enVVeno Medical Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-546 000 (0.00 %) |
EPS: | $-1.910 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-546 000 (0.00 %) |
EPS: | $-1.910 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-525 000 (0.00 %) |
EPS: | $-2.16 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-12.80 |
Financial Reports:
No articles found.
enVVeno Medical
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators